SG Americas Securities LLC Has $3.71 Million Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

SG Americas Securities LLC trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 54.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,139 shares of the medical instruments supplier's stock after selling 3,772 shares during the quarter. SG Americas Securities LLC's holdings in Mettler-Toledo International were worth $3,707,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Allworth Financial LP increased its stake in shares of Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after acquiring an additional 169 shares during the last quarter. Royal Bank of Canada increased its stake in shares of Mettler-Toledo International by 7.3% in the 4th quarter. Royal Bank of Canada now owns 45,756 shares of the medical instruments supplier's stock valued at $55,990,000 after acquiring an additional 3,105 shares during the last quarter. Impax Asset Management Group plc increased its stake in shares of Mettler-Toledo International by 5.8% in the 4th quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock valued at $243,331,000 after acquiring an additional 10,830 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of Mettler-Toledo International by 31.3% in the 4th quarter. Renaissance Technologies LLC now owns 12,600 shares of the medical instruments supplier's stock valued at $15,418,000 after acquiring an additional 3,000 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in shares of Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier's stock valued at $335,977,000 after acquiring an additional 33,456 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Price Performance

NYSE:MTD traded up $27.49 during trading hours on Monday, reaching $1,182.91. 132,386 shares of the stock were exchanged, compared to its average volume of 151,766. Mettler-Toledo International Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The firm has a 50 day moving average of $1,105.54 and a 200 day moving average of $1,203.68. The stock has a market cap of $24.58 billion, a PE ratio of 29.19, a PEG ratio of 3.30 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $8.89 EPS. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

MTD has been the subject of several research analyst reports. Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price objective for the company from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $1,302.11.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director now owns 120 shares in the company, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.